Senior Scientist, Bispecific Antibody Discovery – Autoimmune
Dualitas Therapeutics
Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Benefits offered by this job
Job summary
Dualitas Therapeutics in South San Francisco, CA, seeks a Senior Scientist to drive discovery and portfolio entry of novel bispecific antibodies through high-throughput screening in cell-based assays. The role emphasizes assay development and execution, while collaborating with biotherapeutics, automation, and computational biology team members.
The ideal candidate combines deep expertise in cell biology and in vitro assays with scientific rigor and the ability to thrive in a fast-paced,
Qualifications
- Extensive cell culture experience with in vitro assay development.
- Hands-on expertise in cell-based reporters, primary immune cells, flow cytometry, ELISA, and MSD.
- Strong ability to develop, optimize and troubleshoot robust assay protocols.
- Preferable familiarity with assay miniaturization and high-throughput screening.
- Demonstrated independent scientific achievement in immunology (INDs, patents, publications).
- Excellent time management and collaboration across disciplines.
Responsibilities
- Drive discovery and portfolio entry of novel bispecific antibodies.
- Lead assay development and execution in cell-based systems.
- Collaborate with biotherapeutics, automation, and computational biology teams.
- Manage multiple projects with strong communication and organization.
Skills
Education
Job description
Dualitas Therapeutics in South San Francisco, CA, seeks a Senior Scientist to drive discovery and portfolio entry of novel bispecific antibodies through high-throughput screening in cell-based assays. The role emphasizes assay development and execution, while collaborating with biotherapeutics, automation, and computational biology team members.
The ideal candidate combines deep expertise in cell biology and in vitro assays with scientific rigor and the ability to thrive in a fast-paced,
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
